000 | 01539 a2200421 4500 | ||
---|---|---|---|
005 | 20250516090633.0 | ||
264 | 0 | _c20120628 | |
008 | 201206s 0 0 eng d | ||
022 | _a1365-2516 | ||
024 | 7 |
_a10.1111/j.1365-2516.2012.02797.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeyvandi, F | |
245 | 0 | 0 |
_aManagement of bleeding disorders in adults. _h[electronic resource] |
260 |
_bHaemophilia : the official journal of the World Federation of Hemophilia _cMay 2012 |
||
300 |
_a24-36 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBlood Coagulation Factor Inhibitors _ximmunology |
650 | 0 | 4 |
_aFactor VIII _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemophilia A _xdrug therapy |
650 | 0 | 4 |
_aHemorrhage _xprevention & control |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmune Tolerance _ximmunology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMusculoskeletal Diseases _xetiology |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 |
_avon Willebrand Diseases _xcomplications |
650 | 0 | 4 |
_avon Willebrand Factor _xtherapeutic use |
700 | 1 | _aKlamroth, R | |
700 | 1 | _aCarcao, M | |
700 | 1 | _aFederici, A B | |
700 | 1 | _aDI Minno, G | |
700 | 1 | _aJiménez-Yuste, V | |
700 | 1 | _aRodriguez Merchán, E C | |
773 | 0 |
_tHaemophilia : the official journal of the World Federation of Hemophilia _gvol. 18 Suppl 2 _gp. 24-36 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2516.2012.02797.x _zAvailable from publisher's website |
999 |
_c21728814 _d21728814 |